23 patents
Page 2 of 2
Utility
Corticotropin Releasing Factor Receptor Antagonists
21 Jan 21
The present invention provides novel pharmaceutical compositions comprising -(4-Chloro-2-(morpholin-4-yl)thiazol-5-yl)-7-(1-ethylpropyl)-2,5-dimethylpyrazolo(1,5-a)pyrimidine and methods of using the same for the treatment of Congenital adrenal hyperplasia (CAH).
Alexis HOWERTON, Hal GERBER, Michael HUANG
Filed: 5 Oct 20
Utility
Corticotropin releasing factor receptor antagonists
30 Nov 20
The present invention provides novel pharmaceutical compositions comprising -(4-Chloro-2-(morpholin-4-yl)thiazol-5-yl)-7-(1-ethylpropyl)-2,5-dimethylpyrazolo(1,5-a)pyrimidine and methods of using the same for the treatment of Congenital adrenal hyperplasia (CAH).
Alexis Howerton, Hal Gerber, Michael Huang
Filed: 17 Apr 19
Utility
Corticotropin Releasing Factor Receptor Antagonists
12 Aug 20
The present disclosure provides forms of CRF antagonists and methods using such CRF antagonists for treating diseases.
Alexis HOWERTON, Hal GERBER, Sami KARABORNI, Sangita GHOSH
Filed: 10 Feb 20